Eri Yamamoto, Naoto Tomita, Seiji Sakata, Naoko Tsuyama, Kengo Takeuchi, Yuki Nakajima, Kazuho Miyashita, Takayoshi Tachibana, Hirotaka Takasaki, Masatsugu Tanaka, Chizuko Hashimoto, Hideyuki Koharazawa, Katsumichi Fujimaki, Jun Taguchi, Hiroshi Harano, Shigeki Motomura and Yoshiaki Ishigatsubo MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy Cancer Science 104
Version of Record online: 27 NOV 2013 | DOI: 10.1111/cas.12288
The MIB-1 labeling index of 10% at diagnosis of FL is a useful cut-off point which predicts the PFS and OS. The multivariate analysis also show the independent significances with PFS and OS, respectively.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field